BARDA

Trump Admin Shoots The Messenger As Whistleblower Highlights Ongoing Issues
By | May 14, 2020 5:58 p.m.
There’s Still No ‘Master Plan’ For COVID-19 Response, Whistleblower Says
By | May 14, 2020 1:53 p.m.
It Likely Will Take Longer Than 12-18 Months To Find Safe Vaccine, Whistleblower Testifies
By | May 14, 2020 11:56 a.m.
Gov’t Office Recommends Pausing Demotion Of Whistleblowing Researcher, Lawyers Say
By | May 8, 2020 3:39 p.m.
Government Stockpile Secretary Under Scrutiny For Business Ties To Pharma
By | May 7, 2020 2:31 p.m.
HHS Health Expert Says He Was Demoted For Blowing Whistle On Hydroxychloroquine
By | May 5, 2020 5:08 p.m.
NANTONG, CHINA - FEBRUARY 27 2020: An employee checks the production of chloroquine phosphate, resumed after a 15-year break, in a pharmaceutical company in Nantong city in east China's Jiangsu province Thursday, Feb. 27, 2020. Chloroquine phosphate, an old drug for the treatment of malaria, has shown some efficacy and acceptable safety against COVID-19 associated pneumonia in trials, according to Chinese media. Gov Scientist Says He Was Demoted For Opposing Trump’s Favorite Unproven COVID Drug
By | April 22, 2020 6:05 p.m.
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Investigations Desk:
Reporters:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: